April 11, 2025 - 11:31

In a bold move aimed at increasing transparency in the real estate market, Zillow has announced that it will no longer permit privately marketed homes, commonly referred to as "pocket" listings, to be featured on its platform. This decision is part of a broader initiative to combat the growing trend of off-market listings that limit access for potential buyers and create an uneven playing field in the housing market.
Pocket listings have been a topic of contention within the industry, as they often benefit a select group of agents and clients while excluding the general public from valuable opportunities. By restricting these listings, Zillow aims to promote fairness and accessibility, ensuring that all homes are marketed openly and widely.
This policy change is expected to spark further discussions among real estate professionals, as the industry grapples with the implications of increased transparency. Zillow's decision highlights a significant shift in the market landscape, prioritizing consumer access and engagement in home buying.
June 8, 2026 - 22:27
What history tells us about Marvell's upcoming S&P 500 inclusionMarvell Technology shares have been climbing sharply after the announcement that the company will join the S&P 500 index on June 22. Investors are betting that the move will bring fresh demand from...
June 8, 2026 - 04:51
Is PDD Holdings Inc. (PDD) A Good Stock To Buy Now?A recent discussion on a value investing forum laid out a bullish case for PDD Holdings Inc., the parent company of e-commerce platforms Temu and Pinduoduo. As of late May, shares were trading near...
June 7, 2026 - 03:13
Apple Stock: Buy, Sell, or Hold?Apple`s stock is trading close to an all-time high, and a series of potential catalysts could sustain the upward momentum. The company continues to benefit from strong demand for its latest iPhone...
June 6, 2026 - 22:38
Eli Lilly's $3.8 Billion Vaccine Bets: Here's the Big Story Many Investors Are MissingEli Lilly is making a serious push into the vaccine business. The pharmaceutical giant announced a trio of acquisitions totaling $3.8 billion, aimed at building a new division focused on infectious...